About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Research Sheds Light on Harnessing Anticancer Drugs for the Future Fight Against Influenza

by Kathy Jones on September 6, 2012 at 7:16 PM
Font : A-A+

 Research Sheds Light on Harnessing Anticancer Drugs for the Future Fight Against Influenza

A new cell screening method that can be used to identify potential anti-influenza drugs has been developed by the Medical Systems Virology group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki and its national and international collaborators.

The researchers were able to identify two novel compounds with anti-influenza activity, obatoclax and gemcitabine and prove the efficacy of a previously known drug saliphenylhalamide.

Advertisement

The study was recently accepted for publication in the Journal of Biological Chemistry and is now available online.

Influenza viruses cause significant human morbidity and mortality. To treat the infections, different virus-directed drugs have been developed. However, the currently available drugs are targeting viral proteins and due to a high mutation rate the influenza viruses quickly develop resistance to them. For that reason, next-generation antiviral drugs should be directed towards the host functions. The results of this study provide a foundation for development of next-generation antiviral drugs. Furthermore, these identified compounds can be used as chemical tools when studying the molecular mechanisms of virus-host interactions.
Advertisement

"An interesting aspect of this study is that the antiviral effects of obatoclax, saliphenylhalamide and gemcitabine, which all are either investigational or approved anticancer agents, are achieved at much lower concentrations than that needed to mediate cancer cell death" said the group leader Denis Kainov.

However, further research is still needed before these drugs can be clinically tested and applied in influenza infections.

This research project is a good example of repurposing of drugs, i.e. finding new applications for existing drugs and thus saving money and time on drug development.

"We anticipate that these types of drugs could in the future reinforce the therapeutic arsenal and address the needs of the society to control influenza outbreaks", said Olli Kallioniemi, the Director of FIMM.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
COVID Toes
International Yoga Day 2022 - 'Yoga for Humanity'
Wearable Devices Are Now Transforming Depression, Multiple Sclerosis, and Epilepsy Management.
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Flu Swine Flu Drugs Banned in India Reye’s Syndrome Neutropenic Sepsis 

Most Popular on Medindia

Post-Nasal Drip Drug - Food Interactions Diaphragmatic Hernia Noscaphene (Noscapine) Color Blindness Calculator Hearing Loss Calculator The Essence of Yoga Loram (2 mg) (Lorazepam) Vent Forte (Theophylline) How to Reduce School Bag Weight - Simple Tips

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use